Single-agent capecitabin maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of mCRC

被引：0
|
作者：
Xu, R. [1 ]
Li, Y. [1 ]
Luo, H. [1 ]
Wang, W. [2 ]
Wang, Z. [1 ]
Yuan, X. [3 ]
Ma, D. [4 ]
Wang, F. H. [1 ]
Zhang, D. [1 ]
Lin, D. R. [5 ,6 ]
Jia, J.
Hu, X. H. [7 ]
Peng, J. W. [8 ]
Lin, Y. C. [9 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
[2] Foshan 1 Peoples Hosp, Med Oncol, Foshan, Peoples R China
[3] Huizhou Cent Hosp, Med Oncol, Huizhou, Peoples R China
[4] Guangdong Gen Hosp, Med Oncol, Huizhou, Peoples R China
[5] Jiangmen Cent Hosp, Med Oncol, Jiangmen, Peoples R China
[6] Dongguan Peoples Hosp, Med Oncol, Dongguan, Peoples R China
[7] Guangxi Med Univ, Canc Hosp, Med Oncol, Nanning, Peoples R China
[8] Zhongshan Peoples Hosp, Med Oncol, Zhongshan, Peoples R China
[9] Shantou Univ, Canc Hosp, Med Oncol, Shantou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142O
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] Phase III study of first-line XELOX plus bevacizumab (BEV) for 6 cycles followed by XELOX plus BEV or single-agent (s/a) BEV as maintenance therapy in patients (pts) with metastatic colorectal cancer (mCRC): The MACRO Trial (Spanish Cooperative Group for the Treatment of Digestive Tumors [TTD])
    Tabernero, J.
    Aranda, E.
    Gomez, A.
    Massuti, B.
    Sastre, J.
    Abad, A.
    Valladares, M.
    Rivera, F.
    Safont, M.
    Diaz-Rubio, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Single-agent docetaxel (TXT) as first-line treatment in metastatic breast cancer (MBC)
    Guarneri, D.
    Ratti, R.
    Venturino, A.
    Addamo, G.
    Coccorullo, Z.
    Colloca, G.
    Campora, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Single-agent paclitaxel as first-line treatment of metastatic breast cancer: The British experience
    Davidson, NG
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 6 - 10
  • [24] Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study
    Moscetti, Luca
    Nelli, Fabrizio
    Fabbri, Maria A.
    Sperduti, Isabella
    Alesini, Daniele
    Cortesi, Enrico
    Gemma, Donatello
    Gamucci, Teresa
    Grande, Roberta
    Pavese, Ida
    Franco, Daniela
    Ruggeri, Enzo M.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 1035 - 1043
  • [25] Rituximab Maintenance Therapy After First-Line induction Chemoimmunotherapy for Follicular Lymphoma
    Hilal, Talal
    Leis, Jose F.
    Reeder, Craig B.
    JAMA ONCOLOGY, 2018, 4 (06) : 859 - 860
  • [26] Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study
    Luca Moscetti
    Fabrizio Nelli
    Maria A Fabbri
    Isabella Sperduti
    Daniele Alesini
    Enrico Cortesi
    Donatello Gemma
    Teresa Gamucci
    Roberta Grande
    Ida Pavese
    Daniela Franco
    Enzo M. Ruggeri
    Investigational New Drugs, 2013, 31 : 1035 - 1043
  • [27] Pharmacoeconomic analysis of XELOX versus FOLFOX for metastatic colorectal cancer first-line treatment in Taiwan
    Chen, H. -H.
    Chang, C. -S.
    Chen, L. -T.
    Chen, W. T. -L.
    Hsu, T. -C.
    Wang, J. -Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 54 - 54
  • [28] Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer
    Kamal, A. H.
    Camacho, F.
    Anderson, R.
    Wei, W.
    Balkrishnan, R.
    Kimmick, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 371 - 378
  • [29] Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer
    A. H. Kamal
    F. Camacho
    R. Anderson
    W. Wei
    R. Balkrishnan
    G. Kimmick
    Breast Cancer Research and Treatment, 2012, 134 : 371 - 378
  • [30] T Cell PTLD Successfully Treated With Single-Agent Brentuximab Vedotin First-Line Therapy
    Choi, Mira
    Fink, Susanne
    Prasad, Vikas
    Anagnostopoulos, Ioannis
    Reinke, Petra
    Schmitt, Clemens A.
    TRANSPLANTATION, 2016, 100 (03) : E8 - E10
12345